NCT04494789View on ClinicalTrials.gov

Fludrocortisone Dose Response Relationship in Septic Shock - FluDReSS

PHASE2CompletedINTERVENTIONAL
Enrollment

155

Participants

Timeline

Start Date

February 11, 2021

Primary Completion Date

April 30, 2023

Study Completion Date

June 30, 2023

Conditions
Critically IllSeptic Shock
Interventions
DRUG

Fludrocortisone Acetate

50mcg

DRUG

Fludrocortisone Acetate

100mcg

DRUG

Fludrocortisone Acetate

200mcg

OTHER

Standard Therapy

NO Fludrocortisone

Trial Locations (9)

4101

Mater Misericordiae, Raymond Terrace

4102

Princess Alexandra Hospiital, Woolloongabba

Unknown

Blacktown Hospital, Sydney

Royal North Shore Hospital, Sydney

Royal Brisbane Women's Hospital, Brisbane

Wesley Hospital, Brisbane

Gold Coast University Hospital, Gold Coast

Queen Elizabeth II Hospital, Adelaide

Austin Hospital, Melbourne

All Listed Sponsors
lead

The George Institute

OTHER

NCT04494789 - Fludrocortisone Dose Response Relationship in Septic Shock - FluDReSS | Biotech Hunter | Biotech Hunter